Micafungin in Sodium Chloride
- Product NDC
- 0338-9051
- 11-digit product format
- 003389051
- Labeler code
- 0338
- Product ID
- 0338-9051_c4a06712-4236-4c33-b5ae-77db633e8303
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Micafungin in Sodium Chloride
- Dosage form
- INJECTION
- Route
- INTRAVENOUS
- Labeler
- Baxter Healthcare Corporation
- Application
- NDA216142
- Marketing category
- NDA
- Marketing start
- 2023-09-29
- Substance
- MICAFUNGIN SODIUM
- Active strength
- 50 mg/50mL
- Pharmacologic classes
- Echinocandin Antifungal [EPC], Lipopeptides [CS]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N216142-001 | MICAFUNGIN IN SODIUM CHLORIDE 0.9% | MICAFUNGIN SODIUM | EQ 50MG BASE/50ML (EQ 1MG BASE/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2023-09-29 | |
| N216142-002 | MICAFUNGIN IN SODIUM CHLORIDE 0.9% | MICAFUNGIN SODIUM | EQ 100MG BASE/100ML (EQ 1MG BASE/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2023-09-29 | |
| N216142-003 | MICAFUNGIN IN SODIUM CHLORIDE 0.9% | MICAFUNGIN SODIUM | EQ 150MG BASE/150ML (EQ 1MG BASE/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2023-09-29 |
Orange Book patents#
| Application-product | Patent | Expiration | Use code | Coverage / status | Submission date |
|---|---|---|---|---|---|
| N216142-001 | 12403173 | 2037-12-15 | Drug product | 2025-09-12 | |
| N216142-002 | 12403173 | 2037-12-15 | Drug product | 2025-09-12 | |
| N216142-003 | 12403173 | 2037-12-15 | Drug product | 2025-09-12 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-18 06:07:40 | 2026-07 | N216142-001 | MICAFUNGIN IN SODIUM CHLORIDE 0.9% | EQ 50MG BASE/50ML (EQ 1MG BASE/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2023-09-29 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N216142-002 | MICAFUNGIN IN SODIUM CHLORIDE 0.9% | EQ 100MG BASE/100ML (EQ 1MG BASE/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2023-09-29 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N216142-003 | MICAFUNGIN IN SODIUM CHLORIDE 0.9% | EQ 150MG BASE/150ML (EQ 1MG BASE/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2023-09-29 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | N216142-001 | MICAFUNGIN IN SODIUM CHLORIDE 0.9% | EQ 50MG BASE/50ML (EQ 1MG BASE/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2023-09-29 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N216142-002 | MICAFUNGIN IN SODIUM CHLORIDE 0.9% | EQ 100MG BASE/100ML (EQ 1MG BASE/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2023-09-29 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N216142-003 | MICAFUNGIN IN SODIUM CHLORIDE 0.9% | EQ 150MG BASE/150ML (EQ 1MG BASE/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2023-09-29 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N216142-001 | MICAFUNGIN IN SODIUM CHLORIDE 0.9% | EQ 50MG BASE/50ML (EQ 1MG BASE/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2023-09-29 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N216142-002 | MICAFUNGIN IN SODIUM CHLORIDE 0.9% | EQ 100MG BASE/100ML (EQ 1MG BASE/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2023-09-29 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N216142-003 | MICAFUNGIN IN SODIUM CHLORIDE 0.9% | EQ 150MG BASE/150ML (EQ 1MG BASE/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2023-09-29 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | N216142-001 | MICAFUNGIN IN SODIUM CHLORIDE 0.9% | EQ 50MG BASE/50ML (EQ 1MG BASE/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2023-09-29 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N216142-002 | MICAFUNGIN IN SODIUM CHLORIDE 0.9% | EQ 100MG BASE/100ML (EQ 1MG BASE/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2023-09-29 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N216142-003 | MICAFUNGIN IN SODIUM CHLORIDE 0.9% | EQ 150MG BASE/150ML (EQ 1MG BASE/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2023-09-29 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N216142-001 | MICAFUNGIN IN SODIUM CHLORIDE 0.9% | EQ 50MG BASE/50ML (EQ 1MG BASE/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2023-09-29 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N216142-002 | MICAFUNGIN IN SODIUM CHLORIDE 0.9% | EQ 100MG BASE/100ML (EQ 1MG BASE/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2023-09-29 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N216142-003 | MICAFUNGIN IN SODIUM CHLORIDE 0.9% | EQ 150MG BASE/150ML (EQ 1MG BASE/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2023-09-29 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N216142-001 | MICAFUNGIN IN SODIUM CHLORIDE 0.9% | EQ 50MG BASE/50ML (EQ 1MG BASE/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2023-09-29 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N216142-002 | MICAFUNGIN IN SODIUM CHLORIDE 0.9% | EQ 100MG BASE/100ML (EQ 1MG BASE/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2023-09-29 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N216142-003 | MICAFUNGIN IN SODIUM CHLORIDE 0.9% | EQ 150MG BASE/150ML (EQ 1MG BASE/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2023-09-29 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N216142-001 | MICAFUNGIN IN SODIUM CHLORIDE 0.9% | EQ 50MG BASE/50ML (EQ 1MG BASE/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2023-09-29 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N216142-002 | MICAFUNGIN IN SODIUM CHLORIDE 0.9% | EQ 100MG BASE/100ML (EQ 1MG BASE/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2023-09-29 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N216142-003 | MICAFUNGIN IN SODIUM CHLORIDE 0.9% | EQ 150MG BASE/150ML (EQ 1MG BASE/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2023-09-29 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N216142-001 | MICAFUNGIN IN SODIUM CHLORIDE 0.9% | EQ 50MG BASE/50ML (EQ 1MG BASE/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2023-09-29 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N216142-002 | MICAFUNGIN IN SODIUM CHLORIDE 0.9% | EQ 100MG BASE/100ML (EQ 1MG BASE/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2023-09-29 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N216142-003 | MICAFUNGIN IN SODIUM CHLORIDE 0.9% | EQ 150MG BASE/150ML (EQ 1MG BASE/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2023-09-29 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N216142-001 | MICAFUNGIN IN SODIUM CHLORIDE 0.9% | EQ 50MG BASE/50ML (EQ 1MG BASE/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2023-09-29 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N216142-002 | MICAFUNGIN IN SODIUM CHLORIDE 0.9% | EQ 100MG BASE/100ML (EQ 1MG BASE/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2023-09-29 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N216142-003 | MICAFUNGIN IN SODIUM CHLORIDE 0.9% | EQ 150MG BASE/150ML (EQ 1MG BASE/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2023-09-29 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N216142-001 | MICAFUNGIN IN SODIUM CHLORIDE 0.9% | EQ 50MG BASE/50ML (EQ 1MG BASE/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2023-09-29 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N216142-002 | MICAFUNGIN IN SODIUM CHLORIDE 0.9% | EQ 100MG BASE/100ML (EQ 1MG BASE/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2023-09-29 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N216142-003 | MICAFUNGIN IN SODIUM CHLORIDE 0.9% | EQ 150MG BASE/150ML (EQ 1MG BASE/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2023-09-29 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | N216142-001 | MICAFUNGIN IN SODIUM CHLORIDE 0.9% | EQ 50MG BASE/50ML (EQ 1MG BASE/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2023-09-29 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | N216142-002 | MICAFUNGIN IN SODIUM CHLORIDE 0.9% | EQ 100MG BASE/100ML (EQ 1MG BASE/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2023-09-29 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | N216142-003 | MICAFUNGIN IN SODIUM CHLORIDE 0.9% | EQ 150MG BASE/150ML (EQ 1MG BASE/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2023-09-29 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N216142-001 | MICAFUNGIN IN SODIUM CHLORIDE 0.9% | EQ 50MG BASE/50ML (EQ 1MG BASE/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2023-09-29 | 79d66fd596c7… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N216142-002 | MICAFUNGIN IN SODIUM CHLORIDE 0.9% | EQ 100MG BASE/100ML (EQ 1MG BASE/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2023-09-29 | 79d66fd596c7… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N216142-003 | MICAFUNGIN IN SODIUM CHLORIDE 0.9% | EQ 150MG BASE/150ML (EQ 1MG BASE/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2023-09-29 | 79d66fd596c7… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N216142-001 | MICAFUNGIN IN SODIUM CHLORIDE 0.9% | EQ 50MG BASE/50ML (EQ 1MG BASE/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2023-09-29 | 301d65b070ca… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N216142-002 | MICAFUNGIN IN SODIUM CHLORIDE 0.9% | EQ 100MG BASE/100ML (EQ 1MG BASE/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2023-09-29 | 301d65b070ca… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N216142-003 | MICAFUNGIN IN SODIUM CHLORIDE 0.9% | EQ 150MG BASE/150ML (EQ 1MG BASE/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2023-09-29 | 301d65b070ca… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N216142-001 | MICAFUNGIN IN SODIUM CHLORIDE 0.9% | EQ 50MG BASE/50ML (EQ 1MG BASE/ML) | SOLUTION / INTRAVENOUS | RLD, RS | 2023-09-29 | 1e350fbaab3a… |
Observed Orange Book patent history#
| Captured | Edition | Application-product | Patent | Expiration | Use code | Coverage / status | Submission date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|
| 2026-08-18 06:07:40 | 2026-07 | N216142-001 | 12403173 | 2037-12-15 | Drug product | 2025-09-12 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N216142-002 | 12403173 | 2037-12-15 | Drug product | 2025-09-12 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N216142-003 | 12403173 | 2037-12-15 | Drug product | 2025-09-12 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | N216142-001 | 12403173 | 2037-12-15 | Drug product | 2025-09-12 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N216142-002 | 12403173 | 2037-12-15 | Drug product | 2025-09-12 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N216142-003 | 12403173 | 2037-12-15 | Drug product | 2025-09-12 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N216142-001 | 12403173 | 2037-12-15 | Drug product | 2025-09-12 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N216142-002 | 12403173 | 2037-12-15 | Drug product | 2025-09-12 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N216142-003 | 12403173 | 2037-12-15 | Drug product | 2025-09-12 | 31067a03dcf5… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | N216142-001 | 12403173 | 2037-12-15 | Drug product | 2025-09-12 | a50c72e98297… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | N216142-002 | 12403173 | 2037-12-15 | Drug product | 2025-09-12 | a50c72e98297… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | N216142-003 | 12403173 | 2037-12-15 | Drug product | 2025-09-12 | a50c72e98297… |
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Micafungin in Sodium Chloride
- Listing expiration
- 2027-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| MICAFUNGIN SODIUM | 50 mg/50mL |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| IS1UP79R56 | Internal UNII lookup |
Harmonized RxCUI identifiers#
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| a95f901e-0ac4-4ec0-9720-9c6a066cd06c | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 04f262d4-f446-4cf7-b4fa-28b038cd7ee4 | Product name | 7 | 20260113 |
| 9c331f34-aa42-465c-8abd-4e929fba4e94 | Product name | 1 | 20250625 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0338-9051-01 | Micafungin in Sodium Chloride | 1 in 1 CARTON | INJECTION | 1 | 4 | |
| 0338-9051-01 | Micafungin in Sodium Chloride | 50 mL in 1 BAG | INJECTION | 50 | 4 | |
| 0338-9051-12 | Micafungin in Sodium Chloride | 12 in 1 CARTON | INJECTION | 12 | 4 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0338-9051-01 | ML - Milliliter | 0338-9051 | 6018d3a1-a870-4294-93dd-74c1934d520b | 1 | 2024-06-10 |
| 0338-9051-12 | ML - Milliliter | 0338-9051 | 29177c7b-0f27-463d-b102-a488d39b1cae | 1 | 2024-06-10 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Micafungin in Sodium Chloride | MICAFUNGIN IN SODIUM CHLORIDE | Baxter Healthcare Corporation | a95f901e-0ac4-4ec0-9720-9c6a066cd06c | 2023-09-29 | Warnings, Adverse reactions | 216142 NDA216142 0338-9051 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 2667650 | micafungin 100 MG in 100 ML Injection | PSN | a95f901e-0ac4-4ec0-9720-9c6a066cd06c | 4 |
| 2667652 | micafungin 150 MG in 150 ML Injection | PSN | a95f901e-0ac4-4ec0-9720-9c6a066cd06c | 4 |
| 2667653 | micafungin 50 MG in 50 ML Injection | PSN | a95f901e-0ac4-4ec0-9720-9c6a066cd06c | 4 |
| 2667650 | 100 ML micafungin 1 MG/ML Injection | SCD | a95f901e-0ac4-4ec0-9720-9c6a066cd06c | 4 |
| 2667652 | 150 ML micafungin 1 MG/ML Injection | SCD | a95f901e-0ac4-4ec0-9720-9c6a066cd06c | 4 |
| 2667653 | 50 ML micafungin 1 MG/ML Injection | SCD | a95f901e-0ac4-4ec0-9720-9c6a066cd06c | 4 |
| 2667650 | micafungin 100 MG (equivalent to micafungin sodium 101.73 MG) per 100 ML Injection | SY | a95f901e-0ac4-4ec0-9720-9c6a066cd06c | 4 |
| 2667650 | micafungin 100 MG per 100 ML Injection | SY | a95f901e-0ac4-4ec0-9720-9c6a066cd06c | 4 |
| 2667652 | micafungin 150 MG (equivalent to micafungin sodium 152.6 MG) per 100 ML Injection | SY | a95f901e-0ac4-4ec0-9720-9c6a066cd06c | 4 |
| 2667652 | micafungin 150 MG per 150 ML Injection | SY | a95f901e-0ac4-4ec0-9720-9c6a066cd06c | 4 |
| 2667653 | micafungin 50 MG (equivalent to micafungin sodium 50.87 MG) per 100 ML Injection | SY | a95f901e-0ac4-4ec0-9720-9c6a066cd06c | 4 |
| 2667653 | micafungin 50 MG per 50 ML Injection | SY | a95f901e-0ac4-4ec0-9720-9c6a066cd06c | 4 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 0338-9051-01 | 00338905101 | 1 in 1 CARTON | Historical | ||||
| 0338-9051-12 | 00338905112 | 12 CARTON in 1 CARTON (0338-9051-12) / 1 BAG in 1 CARTON (0338-9051-01) / 50 mL in 1 BAG | 12 carton | 2023-09-29 | No | No | Current |